Biomarin Pharmaceutical Inc
NASDAQ: BMRN
$66.15
+$0.11 (+0.2%)
Closing Price on November 6, 2024
BMRN Articles
One sector that could be poised to do well could be the biotech arena, and the team at RBC has five top stocks for investors to focus on as best ideas.
Published:
ThinkstockIf any sector has had an up and down 2014, it would be the biotech. A massive sell-off in the spring and in the fall has given some biotech investors a serious case of whiplash. However,...
Published:
Monday may have started out as a fairly quiet news day for most stock sectors on a shortened week, but don't tell that to the Ebola drug stocks.
Published:
Monday's top analyst upgrades, downgrades and initiations include BioMarin Pharmaceutical, BP, Home Depot, Petrobras and Target.
Published:
For many of the top biotech companies, orphan drugs have morphed into huge winners and have even generated other streams of revenue.
Published:
Credit Suisse has launched new biotech coverage on Wednesday with two analysts at the firm.
Published:
ThinkstockFor the third time in less than two weeks, one of the top brokerage firms we cover at 24/7 Wall Street has loudly stepped up to the plate and advised investors to buy the top biotech...
Published:
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
Published:
A new report from the equity strategy team at J.P. Morgan presents an extensive list of top names to buy for the next six months in a multitude of categories.
Published:
Last Updated:
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 12, 2014. They include Apache, Apple, Hewlett-Packard, Qualcomm and Sprouts Farmers Market.
Published:
ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of...
Published:
In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are making major advances in cancer therapeutics. Here is the UBS list of stocks that are rated...
Published:
Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many of...
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, March 25, 2014. They include Arch Coal, BlackBerry, Himax Technologies, Palo Alto...
Published:
After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical stocks in early February. The largest upswings happened to BioMarin...
Published: